Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Equilibrative Nucleoside Transport Proteins
The wrong end of the scope.
1330: Brigatinib efficacy and safety in patients (Pts) with anaplastic lymphoma kinase (ALK)-positive (ALK+) non-small cell lung cancer (NSCLC) in a phase 1/2 trial.
Physician perspectives on de-intensifying diabetes medications.
Principal Investigator
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Principal Investigator
Overview
researcher role of
Wainwright, Derek
contributes to
The interaction of IDO and Tregs Leads to Immunosuppression in Glioma